Skip to main content
Ashwin
Conference Coverage
06/09/2023
Dr Ananthakrishnan, from Massachusetts General Hospital in Boston, reviews data from prospective studies on how diet can increase the risk of developing inflammatory bowel disease.
Dr Ananthakrishnan, from Massachusetts General Hospital in Boston, reviews data from prospective studies on how diet can increase the risk of developing inflammatory bowel disease.
Dr Ananthakrishnan, from...
06/09/2023
Advances in Inflammatory Bowel Disease Network
Corey Siegel, MD
Conference Coverage
05/24/2023
Dr Siegel addressed the audience on the need to combine evidence-based medicine from guidelines and research with clinical experience and patient preferences to achieve the best outcomes for patients with Crohn's disease.
Dr Siegel addressed the audience on the need to combine evidence-based medicine from guidelines and research with clinical experience and patient preferences to achieve the best outcomes for patients with Crohn's disease.
Dr Siegel addressed the audience...
05/24/2023
Advances in Inflammatory Bowel Disease Network
Neil Hyman
Conference Coverage
05/16/2023
Dr Hyman explains how surgery can be a highly efficacious option for first-line therapy of penetrating Crohn disease.
Dr Hyman explains how surgery can be a highly efficacious option for first-line therapy of penetrating Crohn disease.
Dr Hyman explains how surgery...
05/16/2023
Advances in Inflammatory Bowel Disease Network
Bincy Abraham, MD
Conference Coverage
04/25/2023
Dr Abraham elaborates on dealing with issues of infection, risks of malignancy, and pregnancy when caring for patients with Crohn disease.
Dr Abraham elaborates on dealing with issues of infection, risks of malignancy, and pregnancy when caring for patients with Crohn disease.
Dr Abraham elaborates on dealing...
04/25/2023
Advances in Inflammatory Bowel Disease Network
Brad D Constant, MD
Conference Coverage
03/31/2023
Dr Constant gave a poster presentation on efficacy and safety data for initiating anti-TNF therapies among children before resolving any internally penetrating Crohn Disease complication.
Dr Constant gave a poster presentation on efficacy and safety data for initiating anti-TNF therapies among children before resolving any internally penetrating Crohn Disease complication.
Dr Constant gave a poster...
03/31/2023
Advances in Inflammatory Bowel Disease Network
Jeffrey Berinstein
Video
03/20/2023
Dr Berinstein recaps his 'pitch' for the use of JAK inhibitors with corticosteroids to control acute severe ulcerative colitis, which he made to the "Shark Tank" panel at the Crohn's & Colitis Congress.
Dr Berinstein recaps his 'pitch' for the use of JAK inhibitors with corticosteroids to control acute severe ulcerative colitis, which he made to the "Shark Tank" panel at the Crohn's & Colitis Congress.
Dr Berinstein recaps his 'pitch'...
03/20/2023
Advances in Inflammatory Bowel Disease Network
fruits+vegetables+nutrition
Conference Coverage
01/22/2023
Family nurse practitioner Andrea Banty spoke highly of the post-operative benefits of a nurse practitioner- and dietician-led structured prehabilitation program for patients with inflammatory bowel disease.
Family nurse practitioner Andrea Banty spoke highly of the post-operative benefits of a nurse practitioner- and dietician-led structured prehabilitation program for patients with inflammatory bowel disease.
Family nurse practitioner Andrea...
01/22/2023
Advances in Inflammatory Bowel Disease Network
smartwatch+technology+wearable device
Conference Coverage
01/22/2023
To assess inflammatory bowel disease data quality and feasibility, the first 125 Apple Watch users to enroll were evaluated. What did the researchers find?
To assess inflammatory bowel disease data quality and feasibility, the first 125 Apple Watch users to enroll were evaluated. What did the researchers find?
To assess inflammatory bowel...
01/22/2023
Advances in Inflammatory Bowel Disease Network
Millie Long
Conference Coverage
01/21/2023
Dr Long spoke at the Crohn's & Colitis Congress 2023 in Denver, Colorado, on the risks of malignancy associated with inflammatory bowel disease and how to discuss absolute risks with patients when choosing therapy.
Dr Long spoke at the Crohn's & Colitis Congress 2023 in Denver, Colorado, on the risks of malignancy associated with inflammatory bowel disease and how to discuss absolute risks with patients when choosing therapy.
Dr Long spoke at the Crohn's &...
01/21/2023
Advances in Inflammatory Bowel Disease Network
Raymond Cross, MD
Conference Coverage
01/21/2023
Understanding how individual extraintestinal manifestations relate to one another can be used to better identify patients at risk of developing future EIMs and may help with risk stratification when choosing treatments.
Understanding how individual extraintestinal manifestations relate to one another can be used to better identify patients at risk of developing future EIMs and may help with risk stratification when choosing treatments.
Understanding how individual...
01/21/2023
Advances in Inflammatory Bowel Disease Network
friends+social+group
Conference Coverage
01/20/2023
Most patients would undergo redo pouch surgery and would recommend it to other people, as it allows for a good quality of life.
Most patients would undergo redo pouch surgery and would recommend it to other people, as it allows for a good quality of life.
Most patients would undergo redo...
01/20/2023
Advances in Inflammatory Bowel Disease Network
Jami Kinnucan
Conference Coverage
01/20/2023
Dr Kinnucan reviews her presentation to advanced practice professionals at the Crohn's & Colitis Congress on implementing a treat to target strategy for patients with inflammatory bowel disease.
Dr Kinnucan reviews her presentation to advanced practice professionals at the Crohn's & Colitis Congress on implementing a treat to target strategy for patients with inflammatory bowel disease.
Dr Kinnucan reviews her...
01/20/2023
Advances in Inflammatory Bowel Disease Network
prescription
Conference Coverage
01/20/2023
Understanding the drug-drug interaction between Paxlovid and tacrolimus among patients with inflammatory bowel disease would help doctors and patients make better decisions about the medication.
Understanding the drug-drug interaction between Paxlovid and tacrolimus among patients with inflammatory bowel disease would help doctors and patients make better decisions about the medication.
Understanding the drug-drug...
01/20/2023
Advances in Inflammatory Bowel Disease Network
colonoscopy shot
Conference Coverage
10/05/2022
A new study shows that the Simplified Endoscopic Mucosal Assessment of Crohn Disease is an easier and equally reliable method for measuring endoscopic remission, Jeremy Adler, MD, said at the Crohn’s & Colitis Congress.
A new study shows that the Simplified Endoscopic Mucosal Assessment of Crohn Disease is an easier and equally reliable method for measuring endoscopic remission, Jeremy Adler, MD, said at the Crohn’s & Colitis Congress.
A new study shows that the...
10/05/2022
Gastroenterology
Sara Horst
Conference Coverage
01/24/2022
Dr Horst, from Vanderbilt University Medical Center, discusses her review of available biologic therapeutics and their application in both Crohn disease and ulcerative colitis from the Crohn's & Colitis Congress 2022.
Dr Horst, from Vanderbilt University Medical Center, discusses her review of available biologic therapeutics and their application in both Crohn disease and ulcerative colitis from the Crohn's & Colitis Congress 2022.
Dr Horst, from Vanderbilt...
01/24/2022
Advances in Inflammatory Bowel Disease Network
A person wearing a smart watch
Conference Coverage
01/24/2022
Fernando Velayos, MD, and Sravanthi Parasa, MD, reviewed the methods currently used for telehealth and how to optimize and expand its implementation among patients with inflammatory bowel disease.
Fernando Velayos, MD, and Sravanthi Parasa, MD, reviewed the methods currently used for telehealth and how to optimize and expand its implementation among patients with inflammatory bowel disease.
Fernando Velayos, MD, and...
01/24/2022
Advances in Inflammatory Bowel Disease Network
Kelly Issokson, RD
Conference Coverage
01/24/2022
Kelly Issokson, RD, discussed how to identify and assess inpatient malnutrition among patients with inflammatory bowel disease.
Kelly Issokson, RD, discussed how to identify and assess inpatient malnutrition among patients with inflammatory bowel disease.
Kelly Issokson, RD, discussed...
01/24/2022
Advances in Inflammatory Bowel Disease Network
Jean Ashburn
Conference Coverage
01/22/2022
Early involvement of a surgeon who specializes in inflammatory bowel disease can optimize outcomes for hospitalized patients with ulcerative colitis, said Jean Ashburn, MD, at the Crohn's & Colitis Congress.
Early involvement of a surgeon who specializes in inflammatory bowel disease can optimize outcomes for hospitalized patients with ulcerative colitis, said Jean Ashburn, MD, at the Crohn's & Colitis Congress.
Early involvement of a surgeon...
01/22/2022
Advances in Inflammatory Bowel Disease Network
Frank Scott, MD
Conference Coverage
01/22/2022
Frank Scott, MD, from the University of Colorado, discussed his study on simulating treatment algorithms to position therapies for moderate to severe ulcerative colitis at the 2022 Crohn’s and Colitis Congress.
Frank Scott, MD, from the University of Colorado, discussed his study on simulating treatment algorithms to position therapies for moderate to severe ulcerative colitis at the 2022 Crohn’s and Colitis Congress.
Frank Scott, MD, from the...
01/22/2022
Advances in Inflammatory Bowel Disease Network
Dolinger
Conference Coverage
01/22/2022
In this video, Dr Dolinger, from the Icahn School of Medicine at Mt Sinai in New York, reviews his abstract presented at the Crohn's & Colitis Congress 2022 about using intestinal ultrasound to detect recurrence of Crohn disease following...
In this video, Dr Dolinger, from the Icahn School of Medicine at Mt Sinai in New York, reviews his abstract presented at the Crohn's & Colitis Congress 2022 about using intestinal ultrasound to detect recurrence of Crohn disease following...
In this video, Dr Dolinger, from...
01/22/2022
Advances in Inflammatory Bowel Disease Network
Séverine Vermeire, MD, PhD
Conference Coverage
01/21/2022
At Crohn's & Colitis Congress 2022, Dr Vermeire reviewed new endpoints for clinical trials and goals for inflammatory bowel disease management as they have evolved throughout the past 2 decades.
At Crohn's & Colitis Congress 2022, Dr Vermeire reviewed new endpoints for clinical trials and goals for inflammatory bowel disease management as they have evolved throughout the past 2 decades.
At Crohn's & Colitis Congress...
01/21/2022
Advances in Inflammatory Bowel Disease Network
Jean Fred
Conference Coverage
01/21/2022
In his keynote address to the Crohn’s & Colitis Congress, Dr Colombel urged better application of existing therapeutics and exploring the use of “rational combinations” of therapies to achieve better outcomes in inflammatory bowel disease.
In his keynote address to the Crohn’s & Colitis Congress, Dr Colombel urged better application of existing therapeutics and exploring the use of “rational combinations” of therapies to achieve better outcomes in inflammatory bowel disease.
In his keynote address to the...
01/21/2022
Advances in Inflammatory Bowel Disease Network
Robert Battat
Conference Coverage
01/21/2022
When conventional treatments fail, dual therapies with biologics and small molecules should be considered, Robert Battat, MD, said at the Crohn’s & Colitis Congress.
When conventional treatments fail, dual therapies with biologics and small molecules should be considered, Robert Battat, MD, said at the Crohn’s & Colitis Congress.
When conventional treatments...
01/21/2022
Advances in Inflammatory Bowel Disease Network
Ashwin Ananthakrishnan, MD, MPH
Conference Coverage
01/21/2022
Dr Ananthakrishnan, from Massachusetts General Hospital in Boston, discusses his presentation about the Clinical Year in Review from the 2022 Crohn's and Colitis Congress, on important research published and its implications for IBD care.
Dr Ananthakrishnan, from Massachusetts General Hospital in Boston, discusses his presentation about the Clinical Year in Review from the 2022 Crohn's and Colitis Congress, on important research published and its implications for IBD care.
Dr Ananthakrishnan, from...
01/21/2022
Advances in Inflammatory Bowel Disease Network
Edward Barnes, MD
Conference Coverage
01/20/2022
Dr Barnes reviews a case-based discussion at the Crohn's & Colitis Congress on managing ulcerative colitis.
Dr Barnes reviews a case-based discussion at the Crohn's & Colitis Congress on managing ulcerative colitis.
Dr Barnes reviews a case-based...
01/20/2022
Advances in Inflammatory Bowel Disease Network
Dolinger
Conference Coverage
01/20/2022
Dr Dolinger, from the Icahn School of Medicine at Mt Sinai in New York, discusses the use of advanced imaging such as intestinal ultrasound in managing inflammatory bowel disease among pediatric patients.
Dr Dolinger, from the Icahn School of Medicine at Mt Sinai in New York, discusses the use of advanced imaging such as intestinal ultrasound in managing inflammatory bowel disease among pediatric patients.
Dr Dolinger, from the Icahn...
01/20/2022
Advances in Inflammatory Bowel Disease Network
Stefan Holubar, MD, on Biologics Before IBD Surgery: Are There Risks of Complications?
Videos
02/03/2021
Dr Holubar, from the Cleveland Clinic, discusses his research into the question of whether patients who take biologic therapies prior to surgery for IBD are more likely to develop postoperative complications.
Dr Holubar, from the Cleveland Clinic, discusses his research into the question of whether patients who take biologic therapies prior to surgery for IBD are more likely to develop postoperative complications.
Dr Holubar, from the Cleveland...
02/03/2021
Advances in Inflammatory Bowel Disease Network
Russell Cohen, MD, on Positioning JAK Inhibitors and Other Small Molecules in IBD
Videos
01/23/2021
Dr Cohen, director of the IBD Center at the University of Chicago, recaps his presentation at the Crohn's & Colitis Congress 2021 on using novel small molecule agents to treat inflammatory bowel disease.
Dr Cohen, director of the IBD Center at the University of Chicago, recaps his presentation at the Crohn's & Colitis Congress 2021 on using novel small molecule agents to treat inflammatory bowel disease.
Dr Cohen, director of the IBD...
01/23/2021
Advances in Inflammatory Bowel Disease Network
Stephen Hanauer, MD, on Emerging Therapies for IBD
Videos
01/23/2021
In this video, Dr Hanauer, from the Feinberg School of Medicine at Northwestern University in Chicago, reviews his presentation at the Crohn's & Colitis Congress 2021 on "evolutionary" agents on the horizon for treatment of inflammatory bowel...
In this video, Dr Hanauer, from the Feinberg School of Medicine at Northwestern University in Chicago, reviews his presentation at the Crohn's & Colitis Congress 2021 on "evolutionary" agents on the horizon for treatment of inflammatory bowel...
In this video, Dr Hanauer, from...
01/23/2021
Advances in Inflammatory Bowel Disease Network
Maria Abreu, MD, on Translating Basic Research to the IBD Clinic
Videos
01/21/2021
In this video, Dr Abreu, director of the Crohn's and Colitis Center at the University of Miami Miller School of Medicine, previews her talk for the Crohn's & Colitis Congress 2021 on how basic research is being translated to advances in...
In this video, Dr Abreu, director of the Crohn's and Colitis Center at the University of Miami Miller School of Medicine, previews her talk for the Crohn's & Colitis Congress 2021 on how basic research is being translated to advances in...
In this video, Dr Abreu,...
01/21/2021
Advances in Inflammatory Bowel Disease Network
Erica Brenner, MD, on Pediatric IBD Care in the Age of COVID-19
Videos
01/21/2021
Dr Brenner discusses her presentation at the Crohn's & Colitis Congress on what data indicate about the risks and disease course of pediatric patients with inflammatory bowel disease during the COVID-19 pandemic.
Dr Brenner discusses her presentation at the Crohn's & Colitis Congress on what data indicate about the risks and disease course of pediatric patients with inflammatory bowel disease during the COVID-19 pandemic.
Dr Brenner discusses her...
01/21/2021
Advances in Inflammatory Bowel Disease Network
What Does It Mean To Be Well?
Commentary
01/15/2021
In this commentary, Laurie Keefer, PhD, AGAF, from the Icahn School of Medicine at Mount Sinai in New York, challenges gastroenterologists to take a more holistic view of their patients with inflammatory bowel disease, and to look beyond...
In this commentary, Laurie Keefer, PhD, AGAF, from the Icahn School of Medicine at Mount Sinai in New York, challenges gastroenterologists to take a more holistic view of their patients with inflammatory bowel disease, and to look beyond...
In this commentary, Laurie...
01/15/2021
Advances in Inflammatory Bowel Disease Network
Laura Targownik
Video
02/23/2012
Dr Targownik reviews the potential applications of combined therapies for inflammatory bowel disease that target different pathways to provide better outcomes.
Dr Targownik reviews the potential applications of combined therapies for inflammatory bowel disease that target different pathways to provide better outcomes.
Dr Targownik reviews the...
02/23/2012
Advances in Inflammatory Bowel Disease Network
Videos
01/22/2010
Dr Cohen reviews his presentation from the Crohn's & Colitis Congress 2021 about positioning novel small molecule therapies, including JAK inhibitors, in the treatment of inflammatory bowel disease.   Russell Cohen, MD, is a professor of...
Dr Cohen reviews his presentation from the Crohn's & Colitis Congress 2021 about positioning novel small molecule therapies, including JAK inhibitors, in the treatment of inflammatory bowel disease.   Russell Cohen, MD, is a professor of...
Dr Cohen reviews his...
01/22/2010
Advances in Inflammatory Bowel Disease Network